ONEMEDNET CORPORATION
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $1.4M | $643.0K | $1.0M | $1.2M |
| Cost of Revenue | $1.9M | $924.0K | $1.2M | $1.5M |
| Gross Profit | $-503.0K | $-281.0K | $-129.0K | $-360.0K |
| Gross Margin | -37.0% | -43.7% | -12.6% | -31.2% |
| Operating Expenses | ||||
| Research & Development | $1.5M | $1.5M | $2.1M | $1.6M |
| SG&A Expense | $6.4M | $7.0M | $3.5M | $4.8M |
| Operating Income | $-9.7M | $-9.6M | $-6.9M | $-7.7M |
| Operating Margin | -711.3% | -1,493.8% | -671.2% | -669.1% |
| Interest Expense | — | — | $11.0K | $403.3K |
| Pretax Income | $-2.8M | $-10.1M | $-33.8M | $-30.4M |
| Income Tax Expense | $1.0K | $2.0K | $18.0K | $17.0K |
| Net Income | $-2.8M | $-10.1M | $-33.8M | $-30.5M |
| Net Margin | -206.1% | -1,575.3% | -3,308.5% | -2,641.0% |
| EPS (Basic) | $-0.06 | $-0.36 | $-1.16 | $-1.92 |
| EPS (Diluted) | $-0.06 | $-0.36 | $-1.16 | $-1.92 |
| Shares Outstanding (Basic) | 44.5M | 28.1M | 29.1M | 15.9M |
| Shares Outstanding (Diluted) | 44.5M | 28.1M | 29.1M | 15.9M |
| Dividends Per Share | — | — | — | — |